Standout Papers

Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma a... 2010 2026 2015 2020 625
  1. Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts (2010)
    Sergio A. Quezada, Tyler R. Simpson et al. The Journal of Experimental Medicine
  2. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study (2016)
    Xiaozhou Fan, Alexander V. Alekseyenko et al. Gut
  3. Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer (2018)
    Richard B. Hayes, Jiyoung Ahn et al. JAMA Oncology
  4. Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy (2014)
    Xiaozhou Fan, Sergio A. Quezada et al. The Journal of Experimental Medicine

Immediate Impact

62 by Nobel laureates 44 from Science/Nature 108 standout
Sub-graph 1 of 18

Citing Papers

Naturally occurring T cell mutations enhance engineered T cell therapies
2024 StandoutNature
Immune checkpoint therapy—current perspectives and future directions
2023 StandoutNobel
12 intermediate papers

Works of Xiaozhou Fan being referenced

Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study
2016 Standout
Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy
2014 StandoutNobel
and 2 more

Author Peers

Author Last Decade Papers Cites
Xiaozhou Fan 930 38 465 812 706 25 2.1k
Mauro Castellarin 820 2 215 423 1294 17 2.2k
Mara Roxana Rubinstein 689 12 341 169 1549 14 2.3k
Robert O. Greer 491 8 506 138 324 52 2.1k
Krisanavane Reddi 196 8 381 368 607 27 1.4k
Joyce Eskdale 594 68 150 1817 443 46 3.0k
Leonard C. Altman 160 14 467 729 358 58 2.4k
Jens Sandros 279 10 915 229 382 33 1.9k
Abhishek V. Garg 370 21 51 1672 489 17 2.6k
Ulf Forssmann 630 17 41 1132 595 33 2.2k
M. Parkar 175 45 1338 377 617 40 2.4k

All Works

Loading papers...

Rankless by CCL
2026